Media-OutReach Newswire Health2Sync and Novo Nordisk Pharma Korea, Ltd. Launch Smart Cap Mallya® for FlexTouch® Insulin Pens Integration in South Korea, Enhancing insulin administration via Digital Diabetes Care
Five-year visa exemption considered for global talents, including top scientists, executives, artists 3.